Nikolas Gaio was born in Feltre, Italy in 1990. He received the B.S degree in electronic engineering from the Polytechnic University of Milan, Milan, Italy in 2012. In 2011 he was visiting student at Tongji University, Shanghai, China, where he received a B.Eng. in Electronic Information in 2013. In 2013, he joined as guest researcher the Shenzhen Institute of Advanced Technology (Chinese Academy of Science). In 2015 he received a M.Sc. (cum laude) in Biomedical Engineering at the Faculty of Mechanical, Maritime and Materials Engineering in TU Delft.
In 2019 he received his Ph.D. at the Department of Microelectronics, Delft University of Technology, The Netherlands. During his PhD, he received the Best Student Paper Award at the 2015 IEEE Sensors, the public Poster Award at the ICT Open Conference in 2016 and the young researcher Lush Prize in 2018. Nikolas Gaio is the founder of BI/OND (BIOND Solution B.V.) where is currently working. The BI/OND team was awarded with the Accenture Innovation Award in 2018 and the Philips Innovation Award in 2019.
Luncheon Technology Spotlight Presentation: BI/OND: Versatile Organ-on-Chip platform for 3D Tissues
Friday, 14 June 2019 at 13:15
Add to Calendar ▼2019-06-14 13:15:002019-06-14 14:15:00Europe/LondonLuncheon Technology Spotlight Presentation: BI/OND: Versatile Organ-on-Chip platform for 3D Tissues3D-Culture, Organoids and Tox Screening Europe 2019 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com
Nowadays, biologists must choose between two options when running pre-clinical models in the early phase of drug testing: in vivo studies conducted on animals or in vitro screening. However, in vitro model and animals have shown to be inadequate for testing new pharmaceuticals to treat the many diseases that afflict humans. To achieve better medicine, there is a considerable need for more accurate human-representative systems. Therefore, biologists developed high-content 3D tissue models (organoids, microtissues, patient-derived tissues, etc..). However, they found that maintaining these 3D tissue models alive it is extremely complex. In particular, it is fundamental to control oxygen gradients and nutrients using a dynamic system. BIOND Solutions (BI/OND) supports biologists working in pharmaceutical companies, biotech and academia to explore fundamental questions about human health and diseases by providing versatile, dynamic chips for 3D tissue models. The approach consists in combining human cells, or patient-derived tissue with the use of a microfluidic chip.
Add to Calendar ▼2019-06-13 00:00:002019-06-14 00:00:00Europe/London3D-Culture, Organoids and Tox Screening Europe 20193D-Culture, Organoids and Tox Screening Europe 2019 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com
Add to Calendar ▼2019-06-14 13:15:002019-06-14 14:15:00Europe/LondonLuncheon Technology Spotlight Presentation: BI/OND: Versatile Organ-on-Chip platform for 3D Tissues3D-Culture, Organoids and Tox Screening Europe 2019 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com
